Once again this year, IBSA participated in the IMCAS World Congress 2026 in Paris, held from 29 January to 1 February. The company consolidated its pioneering role in aesthetic medicine, articulating a new narrative centred on regenerative approaches.
Therapeutic Areas
IMCAS World Congress 2026: IBSA, A Protagonist in Regenerative Aesthetic Medicine
THE "THE NEW FRONTIER OF HYBRID REGENERATION" SYMPOSIUM AND THE PODIUM AT THE INDUSTRY INNOVATION AWARDS
IBSA hosted the symposium, "NAHYCO® FULL FACE: The New Frontier of Hybrid Regeneration," which provided a platform for over 650 international experts. These specialists delved into advanced regenerative aesthetic treatments designed for both women and men.
Furthermore, a product from IBSA’s PROFHILO® line secured second place at the Industry Innovation Awards, thanks to the innovative NAHYCO® Hybrid Technology, which enables a high concentration of hyaluronic acid (HA) without chemical cross-linkers.
As is the case every year, Luca Crippa, Chief Commercial Officer, was a guest at the round table that brought together representatives of the main companies in the sector, and he reiterated IBSA’s strong leadership in the injectable aesthetic medicine sector: “With our Hybrid Cooperative Complexes (HCCs), launched in 2015, IBSA pioneered a new generation of hyaluronic acid in regenerative aesthetics. Our R&D continues to work on future innovations, combining HA with other substances to advance next-generation approaches, always focused on patients' wellbeing.”
CONSTANT COMMITMENT TO INNOVATION AND AUTHENTIC BEAUTY
IBSA's commitment to innovation and authentic beauty continues to drive the development of its aesthetic medicine products. Through constant investments in research and training, IBSA remains at the forefront of regenerative aesthetics, with a strong reputation built on scientific credibility and a constant attention to the needs of specialists and patients.
Further reinforcing this scientific vision, Mauro Ninci, Chief Scientific Officer, stated: “NAHYCO® Hybrid Technology represents an innovative approach to rejuvenation, fostering tissue remodelling and delivering sustainable, long-term outcomes. With NAHYCO®, we have set new benchmarks in regenerative aesthetic medicine, developing solutions that improve skin firmness, tone, and elasticity while respecting physiology.”
